10 - 2020 | Urgent Family Care

- OCTOBER 23, 2020
- 0
Coronavirus (COVID-19) | Medical Study | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals
Study Name: Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals Question: Is race associated with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) in the United States? Findings: In this cohort study of 11 210 individuals with COVID-19 presenting for care at 92 hospitals across 12
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19
- OCTOBER 23, 2020
- 0
COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19
Convalescent plasma is ineffective for covid-19 Editorial Article Lessons from the Placid Trial Convalescent plasma generated great enthusiasm in the earliest days of the coronavirus disease 2019 (covid-19) pandemic because of a plausible mechanism of action,1 its 100 year history of use in the treatment of other infectious diseases,2 and rapid availability from voluntary donors.3 In the
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19
- OCTOBER 23, 2020
- 0
COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) Research Abstract Objective: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India. Design: Open label, parallel arm, phase II, multicentre, randomised controlled trial.
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19
- OCTOBER 23, 2020
- 0
COVID-19 | Research Study | Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 Research Study Abstract BACKGROUND Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials. METHODS : In this randomized, controlled, open-label platform trial comparing a range of possible
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19
- OCTOBER 23, 2020
- 0
COVID-19 | Research Study | Remdesivir has little or no impact on survival, W.H.O. trial shows
Remdesivir has little or no impact on survival for COVID-19, WHO trial shows. The largest trial to date of treatments repurposed for use in the covid-19 pandemic has shown that none of the four drugs studied produced any measurable benefit in mortality or disease course. This includes remdesivir—a drug already recommended by several guidelines
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19
- OCTOBER 23, 2020
- 0
COVID-19 Update | FDA News Release | FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19. Based on scientific evidence available, the FDA concluded, as outlined in its decision memorandum, this product may be effective in treating
Read more
- Hassan Nadrous
- Coronavirus (SARS-CoV-2) | COVID-19,
- FDA News Release

Monthly archives: October, 2020

Coronavirus (COVID-19) | Medical Study | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19

COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

COVID-19 | Research Study | Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

COVID-19 | Research Study | Remdesivir has little or no impact on survival, W.H.O. trial shows

COVID-19 Update | FDA News Release | FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic

Categories

Most Viewed

Most Commented

Archives

Our Services

Schedule Walk-In Visit

Latest Posts

Blog

Knoxville Clinic